These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 22027448)
21. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. Ray A; Basu S; Williams CB; Salzman NH; Dittel BN J Immunol; 2012 Apr; 188(7):3188-98. PubMed ID: 22368274 [TBL] [Abstract][Full Text] [Related]
22. Anti-CD20 Depletes Meningeal B Cells but Does Not Halt the Formation of Meningeal Ectopic Lymphoid Tissue. Brand RM; Friedrich V; Diddens J; Pfaller M; Romana de Franchis F; Radbruch H; Hemmer B; Steiger K; Lehmann-Horn K Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34021057 [TBL] [Abstract][Full Text] [Related]
23. Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL. Hirata S; Matsuyoshi H; Fukuma D; Kurisaki A; Uemura Y; Nishimura Y; Senju S J Immunol; 2007 Jan; 178(2):918-25. PubMed ID: 17202353 [TBL] [Abstract][Full Text] [Related]
24. A modified superantigen rescues Ly6G- CD11b+ blood monocyte suppressor function and suppresses antigen-specific inflammation in EAE. Slaney CY; Toker A; Fraser JD; Harper JL; Bäckström BT Autoimmunity; 2013 Jun; 46(4):269-78. PubMed ID: 23374140 [TBL] [Abstract][Full Text] [Related]
25. Selective depletion of CD11c Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697 [TBL] [Abstract][Full Text] [Related]
26. CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells? Agahozo MC; Peferoen L; Baker D; Amor S Mult Scler Relat Disord; 2016 Sep; 9():110-7. PubMed ID: 27645355 [TBL] [Abstract][Full Text] [Related]
27. Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice. Ghosh D; Curtis AD; Wilkinson DS; Mannie MD J Leukoc Biol; 2016 Oct; 100(4):747-760. PubMed ID: 27256565 [TBL] [Abstract][Full Text] [Related]
28. Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA. Derdelinckx J; Mansilla MJ; De Laere M; Lee WP; Navarro-Barriuso J; Wens I; Nkansah I; Daans J; De Reu H; Jolanta Keliris A; Van Audekerke J; Vanreusel V; Pieters Z; Van der Linden A; Verhoye M; Molenberghs G; Hens N; Goossens H; Willekens B; Cras P; Ponsaerts P; Berneman ZN; Martínez-Cáceres EM; Cools N J Neuroinflammation; 2019 Aug; 16(1):167. PubMed ID: 31416452 [TBL] [Abstract][Full Text] [Related]
29. Experimental autoimmune encephalomyelitis (EAE) induced by antigen pulsed dendritic cells in the C57BL/6 mouse: influence of injection route. Aghdami N; Gharibdoost F; Moazzeni SM Exp Anim; 2008 Jan; 57(1):45-55. PubMed ID: 18256518 [TBL] [Abstract][Full Text] [Related]
30. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Mendel I; Kerlero de Rosbo N; Ben-Nun A Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871 [TBL] [Abstract][Full Text] [Related]
31. Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase. Bhowmick S; Clark RB; Brocke S; Cone RE Int Immunol; 2011 Feb; 23(2):119-28. PubMed ID: 21273399 [TBL] [Abstract][Full Text] [Related]
32. Depletion of CD4(+)CD25(+) T cells exacerbates experimental autoimmune encephalomyelitis induced by mouse, but not rat, antigens. Akirav EM; Bergman CM; Hill M; Ruddle NH J Neurosci Res; 2009 Nov; 87(15):3511-9. PubMed ID: 19125411 [TBL] [Abstract][Full Text] [Related]
34. Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis. Huarte E; Jun S; Rynda-Apple A; Golden S; Jackiw L; Hoffman C; Maddaloni M; Pascual DW J Immunol; 2016 Jun; 196(12):5036-46. PubMed ID: 27194787 [TBL] [Abstract][Full Text] [Related]
35. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237 [TBL] [Abstract][Full Text] [Related]
36. Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes. Weissert R; Wiendl H; Pfrommer H; Storch MK; Schreiner B; Barth S; Seifert T; Melms A; Dichgans J; Weller M J Neuroimmunol; 2003 Nov; 144(1-2):28-37. PubMed ID: 14597095 [TBL] [Abstract][Full Text] [Related]
37. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. Matsushita T; Yanaba K; Bouaziz JD; Fujimoto M; Tedder TF J Clin Invest; 2008 Oct; 118(10):3420-30. PubMed ID: 18802481 [TBL] [Abstract][Full Text] [Related]
38. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody. Alwayn IP; Xu Y; Basker M; Wu C; Buhler L; Lambrigts D; Treter S; Harper D; Kitamura H; Vitetta ES; Abraham S; Awwad M; White-Scharf ME; Sachs DH; Thall A; Cooper DK Xenotransplantation; 2001 Aug; 8(3):157-71. PubMed ID: 11472623 [TBL] [Abstract][Full Text] [Related]
39. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells. Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928 [TBL] [Abstract][Full Text] [Related]
40. Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses. Lee MJ; Jang M; Choi J; Lee G; Min HJ; Chung WS; Kim JI; Jee Y; Chae Y; Kim SH; Lee SJ; Cho IH Mol Neurobiol; 2016 Apr; 53(3):1419-1445. PubMed ID: 25579380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]